title: Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma.
abstract: BACKGROUND
  Cytochrome P-450 2J2 (CYP2J2) has recently been shown to be an important enzyme in the metabolism of epoxygenase-derived eicosanoids that play important functional roles in pulmonary physiology and may contribute to the pathogenesis of asthma.
  
  
  OBJECTIVE
  The focus of our pilot study was to evaluate whether common polymorphism G-50T within the proximal promoter of human CYP2J2 gene is associated with the susceptibility to bronchial asthma.
  
  
  METHODS
  A total of 429 unrelated Russian subjects were recruited in this case-control study, including 215 sex-matched and age-matched patients with asthma and 214 healthy control subjects. The blood samples were analyzed for genetic polymorphism G-50T in the CYP2J2 gene by polymerase chain reaction followed by restriction fragment length polymorphism analysis.
  
  
  RESULTS
  The frequency of variant allele -50T of the CYP2J2 gene was significantly higher in asthmatic patients than in healthy subjects (odds ratio [OR], 5.04; 95% confidence interval [CI], 1.99 to 12.77; p = 0.0003). In addition, the heterozygous genotype -50GT of the CYP2J2 gene was found to be significantly associated with susceptibility to allergic asthma (OR, 5.40; 95% CI, 2.05 to 14.26; p = 0.0003) as well as nonallergic asthma (OR, 5.77; 95% CI, 1.84 to 18.10; p = 0.004). The associations of the CYP2J2 gene G-50T polymorphism with asthma remained significant after adjustment for age and gender using multiple logistic regression analysis.
  
  
  CONCLUSIONS
  Our data demonstrate for the first time that the CYP2J2 gene might be considered as a novel candidate gene for common susceptibility to asthma and highlight the importance of the P-450 epoxygenase pathway of metabolism of arachidonic acid in the pathogenesis of the disease.
authors.affiliation: Kursk State Medical University, Karl Marx St 3, Kursk, Russia 305041. polonikov@rambler.ru
authors.forename: Alexey V
authors.initials: AV
authors.lastname: Polonikov
authors.forename: Vladimir P
authors.initials: VP
authors.lastname: Ivanov
authors.forename: Mariya A
authors.initials: MA
authors.lastname: Solodilova
authors.forename: Irina V
authors.initials: IV
authors.lastname: Khoroshaya
authors.forename: Mikhail A
authors.initials: MA
authors.lastname: Kozhuhov
authors.forename: Valery I
authors.initials: VI
authors.lastname: Panfilov
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D016718:Arachidonic Acid / Q000378:metabolism; D001249:Asthma / Q000201:enzymology / Q000235:genetics*; D016022:Case-Control Studies; D000090762:Cytochrome P-450 CYP2J2; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D015777:Eicosanoids / Q000378:metabolism; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D010105:Oxygenases / Q000235:genetics*; D010865:Pilot Projects; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic / Q000235:genetics*
chemical_list: C000717350:CYP2J2 protein, human; D015777:Eicosanoids; D016718:Arachidonic Acid; D003577:Cytochrome P-450 Enzyme System; D010105:Oxygenases; D000090762:Cytochrome P-450 CYP2J2